Feng Li

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Xiaobin Cui, Shumao Zhang, Yuexun Xu et al. · Journal of Translational Medicine · 2016 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +17

miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma

Chengshuo Zhang, Baomin Chen, Ao Jiao et al. · BMC Cancer · 2018 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy

Feng Li, Tizhi Wu, Yunjie Wang et al. · ACS Central Science · 2025 · 30 citations · Full text

Life Sciences, Oncology, Pharmacology +17

BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.

Feng Li, Laura E. Pascal, Jianhua Zhou et al. · PubMed · 2018 · 20 citations

Medicine, Pharmacology, Urology +17

Sativene Sesquiterpenoids from the Plant Endophytic Fungus <i>Bipolaris victoriae</i> S27 and Their Potential as Plant-Growth Regulators

Xinjia Wang, Zhe Wang, Jing Han et al. · Journal of Agricultural and Food Chemistry · 2024 · 16 citations

Life Sciences, Botany, Plant Sciences +6